(Q38758203)

6 September 2017

NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy (English)

1 reference

6 September 2017

Berthold Hocher

7

0 references

Johannes-Peter Stasch

6

object named as

Johannes-Peter Stasch

1 reference

6 September 2017

Philipp Kalk

1

1 reference

6 September 2017

Michael Godes

2

1 reference

6 September 2017

Katharina Relle

3

1 reference

6 September 2017

Christiane Rothkegel

4

1 reference

6 September 2017

Andreas Hucke

5

1 reference

6 September 2017

language of work or name

English

0 references

publication date

12 June 2006

1 reference

British Journal of Pharmacology

6 September 2017

1 reference

6 September 2017

148

1 reference

6 September 2017

6

1 reference

6 September 2017

853-859

1 reference

describes a project that uses

6 September 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC1617071/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Calcium antagonists: effects on cardio-renal risk in hypertensive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Clinical applications of B-type natriuretic peptide levels in the care of cardiovascular patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Chronic kidney disease: the global challenge

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Oxidative stress in uremia: nature, mechanisms, and potential consequences

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Pathophysiology of hypertensive renal damage: implications for therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Smoking and cardiovascular outcomes in dialysis patients: the United States Renal Data System Wave 2 study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Total nitric oxide production is low in patients with chronic renal disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

An L-arginine/nitric oxide pathway present in human platelets regulates aggregation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Downregulation of nitric oxide synthase in chronic renal insufficiency: role of excess PTH.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Soluble guanylate cyclase: the forgotten sibling.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

The prognostic importance of left ventricular geometry in uremic cardiomyopathy

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Natriuretic peptides--new diagnostic markers in heart disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Effects of chronic renal failure on caveolin-1, guanylate cyclase and AKT protein expression

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Combination therapy with angiotensin-converting enzyme inhibitor and oral adsorbent of uremic toxins can delay the appearance of glomerular sclerosis and interstitial fibrosis in established renal failure

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Relaxin is an independent risk factor predicting death in male patients with end-stage kidney disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Enhanced nitric oxide inactivation and protein nitration by reactive oxygen species in renal insufficiency

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

The use of nitric oxide donors in pharmacological studies.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1617071

Endothelin System–Dependent Cardiac Remodeling in Renovascular Hypertension

31 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJP.0706792

Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF

21 January 2018

1 reference

12 December 2020

Blood pressure-independent effect of angiotensin inhibition on vascular lesions of chronic renal failure

1 reference

12 December 2020

The development of hypertension in the remnant kidney model after either pole resection or partial infarction of the kidney

1 reference

12 December 2020

Changes of vascular architecture independent of blood pressure in experimental uremia

1 reference

12 December 2020

Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure:the effects of ramipril, nifedipine and moxonidine

1 reference

12 December 2020

Downregulation of neuronal nitric oxide synthase in the rat remnant kidney

1 reference

12 December 2020

Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure

1 reference

12 December 2020

Animal models to induce renal failure: a historical survey

1 reference

12 December 2020

Impact of left ventricular hypertrophy on survival in end-stage renal disease

1 reference

12 December 2020

ETA receptor blockade induces fibrosis of the clipped kidney in two-kidney-one-clip renovascular hypertensive rats

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJP.0706792

1 reference

6 September 2017

1 reference

6 September 2017

PubMed publication ID

16770325

1 reference